FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

377186003: Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1202502017 Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1478562017 Antazoline phosphate+naphazoline hydrochloride 5mg/0.5mg solution en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3986511000005115 antazolinphosphat + naphazolinhydrochlorid 5 mg/0,5 mg opløsning da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    antazolinphosphat + naphazolinhydrochlorid 5 mg/0,5 mg opløsning Is a antazolinphosphat false Inferred relationship Some
    antazolinphosphat + naphazolinhydrochlorid 5 mg/0,5 mg opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Antazoline phosphate (substance) false Inferred relationship Some
    antazolinphosphat + naphazolinhydrochlorid 5 mg/0,5 mg opløsning Is a antazolinphosphat + naphazolinhydrochlorid false Inferred relationship Some
    antazolinphosphat + naphazolinhydrochlorid 5 mg/0,5 mg opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Naphazoline hydrochloride false Inferred relationship Some
    antazolinphosphat + naphazolinhydrochlorid 5 mg/0,5 mg opløsning Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Some
    antazolinphosphat + naphazolinhydrochlorid 5 mg/0,5 mg opløsning Is a Product containing naphazoline in ophthalmic dosage form false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start